Cocrystal Pharma Inc. Stock
Your prediction
Cocrystal Pharma Inc. Stock
A very strong showing by Cocrystal Pharma Inc. today, with an increase of €0.050 (6.100%) compared to yesterday's price.
Our community identified positive and negative aspects for Cocrystal Pharma Inc. stock for the coming years. 2 users see the criterium "Worthwhile Investment for the next years" as a plus for the Cocrystal Pharma Inc. stock. On the other hand our users think that "Innovation" could be a problem in the future.
Pros and Cons of Cocrystal Pharma Inc. in the next few years
Pros
?
M***** P*******
?
W********* I********* f** t** n*** y****
?
S********** s********
Cons
?
G***** c******* t* c**********
?
B****
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Cocrystal Pharma Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Cocrystal Pharma Inc. | 6.100% | 16.779% | -3.333% | -38.298% | 6.748% | -62.821% | -91.570% |
| Pacira Pharmaceuticals | -1.850% | -9.402% | -4.505% | 12.766% | -1.852% | -39.429% | -58.431% |
| Corcept Therapeutics Inc. | 0.980% | -3.486% | 16.460% | 56.230% | 40.099% | 237.324% | 426.374% |
| Supernus Pharmaceuticals | -1.060% | -5.076% | -9.223% | 16.875% | -13.023% | 30.769% | 66.964% |
Comments
Cocrystal Pharma, Inc. (NASDAQ: COCP) had its price target lowered by analysts at HC Wainwright from $7.00 to $6.00. They now have a "buy" rating on the stock.
Show more
Ratings data for COCP provided by MarketBeat
Cocrystal Pharma, Inc. (NASDAQ: COCP) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $7.00 price target on the stock.
Show more
Ratings data for COCP provided by MarketBeat
Cocrystal Pharma, Inc. (NASDAQ: COCP) had its price target lowered by analysts at HC Wainwright from $10.00 to $7.00. They now have a "buy" rating on the stock.
Show more
Ratings data for COCP provided by MarketBeat